Analysis of α-fetoprotein mRNA in peripheral blood: Detection and semi- quantitation by reverse transcription polymerase chain reaction

Hepatology Research

Volumn 14, Issue 1, 1999, Pages 1-12

  Luo, Wei ^a,b   Yatsuhashi, Hiroshi ^a   Hamada, Rumiko ^a   Matsumoto, Takehiro ^a   Inoue, Osami ^a   Koga, Michiaki ^a   Yano, Michitami ^a  

^a National Hospital Organization   (Japan)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

(AFP L3); (AFP); (HCC); (PIVKA II); (RT PCR); AFP mRNA; Hepatocellular carcinoma; L. culinaris agglutinin A fetoprotein; Protein induced by vitamin K antagonist II; Reverse transcription polymerase chain reaction; Fetoprotein

Indexed keywords

AGGLUTININ; ALPHA FETOPROTEIN; ANTIVITAMIN K; MESSENGER RNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHRONIC HEPATITIS; DNA SYNTHESIS INHIBITION; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; TUMOR RECURRENCE;

EID: 0033014840     PISSN: 09284346     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1386-6346(98)00098-9     Document Type: Article

References (22)

1. Okuda K. Hepatocellular carcinoma: recent progress. Hepatology. 15:1992;948-963.
2. Belghiti J., Panis Y., Farges O., Benhamou J.P., Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann. Surg. 214:1991;114-117.
3. Tarin D., Price J.E., Kettlewell M.G.W., Souter R.G., Vass A.C.R., Crossley B. Clinicopathological observations on metastases in man studied in patients treated with peritoneovenous shunts. Br. Med. J. 288:1984;749-751.
4. Gitlin D. Normal biology of alpha-fetoprotein. Ann. N.Y. Acad. Sci. 259:1975;7-16.
5. Alpert E., Feller E.R. fetoprotein (AFP) in benign liver disease. Gastroenterology. 74:1978;856-858.
6. Smith B., Selby P., Southgate J., Pittman K., Bradley C., Blair E. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet. 338:1991;1227-1229.
7. Matsumura M., Niwa Y., Kato N. et al. Detection of fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: possible predictor of metastatic hepatocellular carcinoma. Hepatology. 20:1994;1418-1425.
8. Nambu S., Nishimori H., Saeki K., Higuchi K., Watanabe A. fetoprotein messenger RNA in peripheral blood as a marker of circulating hepatocellular carcinoma cells. Int. Hepatol. Commun. 3:1995;217-221.
9. Funaki N.O., Tanaka J., Seto S.I., Kasamatsu T., Kaido T., Imamura M. Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver. Hepatology. 25:1997;564-568.
10. Louha M., Poussin K., Ganne N. et al. Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer. Hepatology. 26:1997;998-1005.
11. Kanbara Y., Maekawa Y., Nakaya S., Ishikawa Y., Kitazawa S. Clinical significance of detection of AFP-mRNA in hepatocellular carcinoma. Acta Hepatol. Jpn. 37:1996;731-737.
12. Hermanek P., Sobin L.H. UICC TNM Classification of Malignant Tumors. 3rd:1992;Springer-Verlag, Berlin.
13. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate phenolchloroform extraction. Anal. Biochem. 162:1987;156-159.
14. Iijima S.N., Hamada H., Reddy P., Kakunaga T. Molecular structure of the human cytoplasmic β-actin gene: Interspecies homology of sequences in the introns. Proc. Natl. Acad. Sci. USA. 82:1985;6133-6137.
15. Yatsuhashi H., Yamasaki K., Aritomi T. et al. Quantitative analysis of interferon/receptor mRNA in the liver of patients with chronic hepatitis C: correlation with serum hepatitis C virus-RNA levels and response to treatment with interferon. J. Gastroenterol. Hepatol. 12:1997;460-467.
16. Kinoshita T., Imamura J., Nagai H., Shimotohno K. Quantitation of gene expression over a wide range by the polymerase chain reaction. Anal. Biochem. 206:1992;231-235.
17. Niwa Y., Matsumura M., Shiratori Y. et al. Quantitation of fetoprotein and albumin messenger RNAs in human hepatocellular carcinoma. Hepatology. 23:1996;1384-1392.
18. Taketa K., Sekiya C., Namiki M. et al. Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions. Gastroenterology. 99:1990;508-518.
19. Inoue S., Nakao A., Harada A., Nonami T., Takagi H. Clinical significance of abnormal prothrombin (DCP) in relation to postoperative survival and prognosis in patients with hepatocellular carcinoma. Am. J. Gastroenterol. 89:1994;2222-2226.
20. Suehiro T., Sugimachi K., Matsumata T., Itasaka H., Taketomi A., Maeda T. Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma. Cancer. 73:1995;2464-2471.
21. Nambu S., Nishimori H., Maekawa M., Higuchi K., Watanabe A. Plasma PIVKA-II values as an indicator of AFP mRNA in the circulation in patients with advanced hepatocellular carcinoma. Hepatol. Res. 8:1997;28-36.
22. Kohler T.H., Labner D., Rost A.K., Thamm B., Pustowoit B., Remke H. Quantitation of mRNA by Polymerase Chain Reaction: Nonradioactive PCR Methods[El1]. 1995;Springer-Verlag, Berlin/Heidelberg.